Tigran Torosian

426 total citations
18 papers, 103 citations indexed

About

Tigran Torosian is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Tigran Torosian has authored 18 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in Tigran Torosian's work include Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Tigran Torosian is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). Tigran Torosian collaborates with scholars based in Poland, Czechia and Germany. Tigran Torosian's co-authors include W Wiktor-Jędrzejczak, Elżbieta Urbanowska, Emilian Snarski, Tomasz Dzieciątkowski, Grzegorz Basak, Edward Franek, W. Wiktor Jędrzejczak, Piotr Boguradzki, Kazimierz Hałaburda and Agnieszka Tomaszewska and has published in prestigious journals such as Blood, BMC Cancer and Diabetes Research and Clinical Practice.

In The Last Decade

Tigran Torosian

16 papers receiving 102 citations

Peers

Tigran Torosian
Margaret Hoyle United States
Francisco Bracho United States
Betsy Valles United States
Patrick Thomas United Kingdom
Juan Rondon United States
Tigran Torosian
Citations per year, relative to Tigran Torosian Tigran Torosian (= 1×) peers Debora Parracciani

Countries citing papers authored by Tigran Torosian

Since Specialization
Citations

This map shows the geographic impact of Tigran Torosian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tigran Torosian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tigran Torosian more than expected).

Fields of papers citing papers by Tigran Torosian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tigran Torosian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tigran Torosian. The network helps show where Tigran Torosian may publish in the future.

Co-authorship network of co-authors of Tigran Torosian

This figure shows the co-authorship network connecting the top 25 collaborators of Tigran Torosian. A scholar is included among the top collaborators of Tigran Torosian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tigran Torosian. Tigran Torosian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hölig, Kristina, Helmuth Schmidt, Gero Hütter, et al.. (2020). Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplantation. 56(3). 635–645. 11 indexed citations
2.
Walicka, Magdalena, Emilian Snarski, Krystyna Jedynasty, et al.. (2018). Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation. Diabetes Research and Clinical Practice. 143. 357–363. 6 indexed citations
3.
Torosian, Tigran, et al.. (2018). Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation. Bone Marrow Transplantation. 54(2). 244–257. 2 indexed citations
4.
Urbanowska, Elżbieta, et al.. (2017). Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors. Annals of Hematology. 96(10). 1735–1739. 16 indexed citations
5.
Torosian, Tigran, et al.. (2017). Bone marrow harvest from unrelated donors—up‐to‐date methodology. European Journal Of Haematology. 99(4). 357–365. 6 indexed citations
6.
Snarski, Emilian, et al.. (2016). Niespokrewnieni dawcy komórek macierzystych — motywacja i satysfakcja w procesie donacji komórek krwiotwórczych. Via Medica Journals. 9(2). 39–44. 1 indexed citations
7.
Butrym, Aleksandra, Ewa Lech‐Marańda, Elżbieta Patkowska, et al.. (2015). Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q). BMC Cancer. 15(1). 508–508. 6 indexed citations
8.
Usnarska‐Zubkiewicz, Lidia, Aleksandra Butrym, Wojciech Legieć, et al.. (2013). Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group. Blood. 122(21). 3236–3236.
9.
Dzieciątkowski, Tomasz, Piotr Boguradzki, Tigran Torosian, et al.. (2011). Disseminated Adenovirus Disease in Immunocompromised Patient Successfully Treated with Oral Ribavirin: A Case Report. Archivum Immunologiae et Therapiae Experimentalis. 59(6). 473–477. 8 indexed citations
10.
Szydlo, Richard, Piotr Rzepecki, Anna Czyż, et al.. (2011). Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT. Annals of Transplantation. 16(4). 47–54. 8 indexed citations
11.
Basak, Grzegorz, Elżbieta Urbanowska, Piotr Boguradzki, et al.. (2011). Booster of plerixafor can be successfully used in addition to chemotherapy-based regimen to rescue stem cell mobilization failure.. Annals of Transplantation. 15(4). 61–7. 8 indexed citations
12.
Basak, Grzegorz, Elżbieta Urbanowska, Magdalena Witkowska, et al.. (2010). CXCR4 inhibitor plerixafor and G-CSF allow for an effective peripheral blood stem cell collection in patients who failed previous mobilization attempt. 1(1). 1 indexed citations
13.
Dzieciątkowski, Tomasz, Grzegorz Basak, Tigran Torosian, et al.. (2010). Detection of β-Herpesviruses in Polish Adult Cord Blood Stem Cell Recipients by Real-Time PCR: Single Centre Study. Archivum Immunologiae et Therapiae Experimentalis. 58(6). 467–472.
14.
Dzieciątkowski, Tomasz, et al.. (2010). Human Herpesvirus 7 in Allogeneic Hemopoietic Stem Cell Transplant Recipients in the Central Clinical Hospital in Warsaw: A Three-Year Survey. Intervirology. 54(1). 25–29. 4 indexed citations
15.
Basak, Grzegorz, Tigran Torosian, Emilian Snarski, et al.. (2010). Hematopoietic stem cell transplantation for T315I-mutated chronic myelogenous leukemia.. PubMed. 15(2). 68–70. 5 indexed citations
16.
Snarski, Emilian, Tigran Torosian, Monika Paluszewska, et al.. (2009). Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells. Polskie Archiwum Medycyny Wewnętrznej. 119(6). 422–426. 12 indexed citations
17.
Dzieciątkowski, Tomasz, et al.. (2008). Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience. Archivum Immunologiae et Therapiae Experimentalis. 56(3). 201–206. 8 indexed citations
18.
Urbanowska, Elżbieta, et al.. (2005). Simultaneous transplantation of two allogeneic units of cord blood in an adult patient with acute myeloblastic leukemia: a case report.. PubMed. 53(4). 364–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026